$13.60
0.24[1.80%]
Last update: 9:17AM Get Real Time Here
Assembly Biosciences
(NASDAQ:ASMB)Latest News for Assembly Biosciences Stock (NASDAQ:ASMB)
Assembly Biosciences Stock (NASDAQ: ASMB)
Categories: All
Monday, April 01, 2024
Thursday, March 28, 2024
Monday, February 12, 2024
Friday, February 09, 2024
Thursday, February 08, 2024
Wednesday, January 17, 2024
Thursday, January 04, 2024
Tuesday, December 12, 2023
Friday, November 24, 2023
Thursday, November 23, 2023
Wednesday, November 22, 2023
Wednesday, November 08, 2023
Wednesday, October 25, 2023
Wednesday, October 18, 2023
Tuesday, October 17, 2023
- Crude Oil Moves Lower; Bank of America Profit Beats ExpectationsLisa Levin - Oct 17, 2023, 2:31PM
- Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Oct 17, 2023, 1:42PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Oct 17, 2023, 1:31PM
- Dow Surges 100 Points; Goldman Sachs Posts Upbeat EarningsLisa Levin - Oct 17, 2023, 11:56AM
- Nasdaq Down Over 1%; US Retail Sales Top ExpectationsLisa Levin - Oct 17, 2023, 10:01AM
- Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's WhyVandana Singh - Oct 17, 2023, 9:51AM
- Assembly Biosciences shares are trading higher after the company and Gilead announced they entered into a 12-year partnership to advance the research and development of novel antiviral therapies.Benzinga Newsdesk - Oct 17, 2023, 9:40AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Oct 17, 2023, 9:06AM
- Market-Moving News for October 17thBenzinga Newsdesk - Oct 17, 2023, 8:42AM
- Under The Partnership Terms, Assembly Bio's $100M From Gilead Consists Of $84.8M Upfront Payment And $15.2M Equity Investment From Gilead At Premium Of 19.9%Benzinga Newsdesk - Oct 17, 2023, 7:43AM
- Gilead Sciences, Assembly Biosciences Have Announced 12-Year Partnership For Antiviral Therapies, With An Initial Focus On Assembly Bio's Herpesviruses, Hepatitis B Virus, And Hepatitis D Virus; Assembly Bio To Receive $100M Upfront PaymentBenzinga Newsdesk - Oct 17, 2023, 7:41AM
- Assembly Biosciences Shares Resume TradeBenzinga Newsdesk - Oct 17, 2023, 7:32AM
- Assembly Biosciences, Inc. Shares To Resume Trade At 7:30 a.m. ET,; Evelo Biosciences, Inc. CS Shares To Resume Trade At 7:30 a.m. ETCharles Gross - Oct 17, 2023, 7:09AM
- Evelo Biosciences, Assembly Biosciences Shares Halted; Pending NewsCharles Gross - Oct 17, 2023, 6:57AM
Tuesday, September 19, 2023
Wednesday, August 09, 2023
Friday, July 14, 2023
Thursday, May 04, 2023
Tuesday, April 18, 2023
Monday, April 03, 2023
Friday, March 24, 2023
Wednesday, March 22, 2023
Wednesday, February 15, 2023
Monday, December 19, 2022
- Assembly Biosciences Shares Gain After Promising Early Cut Data From HBV Infection ProgramsVandana Singh - Dec 19, 2022, 3:19PM
- Assembly Biosciences shares are trading higher after the company announced interim results from two clinical trials evaluating highly potent next-generation core inhibitor candidates ABI-H3733 and ABI-4334.Benzinga Newsdesk - Dec 19, 2022, 8:49AM
- Assembly Biosciences Announces Interim Results From Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 And ABI-4334Benzinga Newsdesk - Dec 19, 2022, 8:10AM